Results 141 to 150 of about 218,320 (272)

Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease. [PDF]

open access: yesCell Rep Med, 2023
Bailey C   +13 more
europepmc   +1 more source

An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease [PDF]

open access: bronze, 2004
Renhao Li   +6 more
openalex   +1 more source

Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response. [PDF]

open access: yesJ Cell Mol Med, 2023
Martinez-Sanchez J   +11 more
europepmc   +1 more source

Sirolimus and tacrolimus without methotrexate as graft-vs.-host disease prophylaxis after matched, related peripheral blood stem cell transplantation: low transplant related morbidity and excellent GVHD control [PDF]

open access: hybrid, 2004
Corey Cutler   +10 more
openalex   +1 more source

Taste and smell disturbances in patients with chronic oral graft vs. host disease: An observational study. [PDF]

open access: yesFront Oral Health, 2022
Boor M   +4 more
europepmc   +1 more source

Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. [PDF]

open access: yes, 1985
Mixed allogeneically reconstituted mice (B10 + B10.D2----B10) that specifically accept B10.D2 tail skin allografts were examined for in vivo and in vitro immunocompetence, patterns of hematopoietic repopulation, and in vitro reactivity.
Barbieri, SA   +4 more
core  

218 Mechanisms of increased IgE synthesis in acute graft vs. host disease (GVHD)

open access: bronze, 1983
J A Saryan   +4 more
openalex   +1 more source

Inflammatory pseudotumor of the lung following invasive aspergillosis in a patient with chronic graft‐vs.‐host disease [PDF]

open access: bronze, 2005
Constanze Priebe‐Richter   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy